article thumbnail

CBD Enhances Glucose Metabolism via Nuclear Receptors

Project CBD

The first evidence of an endocannabinoid interacting with PPARs came in 2002, when a research team in Tennessee showed that a metabolite of 2-AG activated PPAR- a. He had never taken anti-psychotic drugs nor received psychological treatment. Cannabidiol as a potential treatment for psychosis.” 6,7 They wanted to try it.

CBD 294
article thumbnail

Press Release: Cannabis Patient Care™ and Americans for Safe Access Form Partnership

Cannabis Law Report

Through this partnership, we will be able to offer our members and supporters a trusted resource to learn about the latest medical cannabis research, benefits, and treatment options available for patients.”. ASA was founded in 2002 as a vehicle for patients to advocate for the acceptance of cannabis as medicine.

Access 81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Marijuana a Useful Adjunct Treatment for Huntington Disease Symptoms

The Joint Blog

According to a new study published in the Journal of Pharmacy & Pharmaceutical Sciences, using marijuana as an adjunct treatment for Huntington disease (HD) is both effective and safe. Analysis of specific motor symptoms revealed significant improvement after treatment in tremors and rigidity.

article thumbnail

Report Says Cannabis Use Among Pregnant Women Increased During the Pandemic

Veriheal

in 2002 to 7.0% For many adults, cannabis functions as a harmless recreational substance or a medical treatment, leading to questions about why it would be dangerous to consume cannabis while pregnant. While some find crucial relief in cannabis medical treatments during pregnancy, cannabis use may not be worth the risk for others.

article thumbnail

United Nations Annual Drug Report Puts “Unprecedented” Focus On Cannabis & Suggests No Desire For Rescheduling Whatsover

Cannabis Law Report

9-THC, the main psychoactive component in cannabis, rose from about 4 per cent to 16 per cent in the United States over the period 1995–2019, and from about 6 per cent to 11 per cent in Europe over the period 2002–2019. ?9-THC Drug Use Rising, but Science-Based Treatment More Available. According to the Report, the percentage of ?9-THC

article thumbnail

Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw

Cannabis Law Report

Dr. Greenshaw is a Fellow of the Royal Society of Arts; a Fellow of the Canadian College of Neuropsychopharmacology (CCNP), for which he served as President from 2000-2002; and a fellow of the Collegium Internationale Neuropsychopharmacologicum (CINP). “We would like to extend a warm welcome to Andy as he joins the team at Entheon.

article thumbnail

Can cannabis reduce acid reflux?

The Cannigma

2 Another animal study from 2002 used a synthetic cannabinoid receptor agonist (not a phytocannabinoid ) to measure the activity of the CB1 and CB2 receptors on esophageal relaxation. Therefore the potential for larger doses or combinations of THC and CBD to reduce reflux is still in question.

Digestion 119